Ubiquigent And University of Dundee Announce Collaboration To Develop Novel Ubiquitin System Targeted Compound Libraries

DUNDEE, Scotland--(BUSINESS WIRE)--Ubiquigent Limited, a company specialising in ubiquitin cell-signalling system drug discovery capabilities and services, and the Drug Discovery Unit (the DDU) of the University of Dundee, announced today they have entered into a collaboration agreement to develop and market new ubiquitin system targeted compound libraries aimed at discovering potent and selective therapeutics across multiple areas including; cancer, cardiovascular and metabolic, neurological and musculoskeletal, and infection and immunity.

Help employers find you! Check out all the jobs and post your resume.